Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Stryker Corp(SYK US)

$307.15+0.070.02%Ext:$300.63-6.522.12%(Market Closed · 00:00:02 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
SYK US​

Stryker Corp — Company Profile

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Sector
Industrials
Industry
Commercial Services & Supplies
Exchange
UN
CEO
Kevin A. Lobo
Headquarters
Portage, MI, US
IPO Date
Mar 17, 1980
Employees
56,000
Website
www.stryker.com

Key Metrics

Price
$275.43
Market Cap
$105.59B
Revenue (TTM)
$6.02B
Net Income (TTM)
$745.00M
EPS (TTM)
1.95
P/E (TTM)
31.64
P/B (TTM)
4.60
Dividend Yield
114.06%
ROE (TTM)
3.24%
ROA (TTM)
1.61%
Operating Margin
15.55%
Beta
0.17

Dividends

Last Dividend
$0.88
Last Yield
1.14%

Summary

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

Website
www.stryker.com
Location
Portage, MI, US
Phone269 385 2600
Employees56,000
CEOKevin A. Lobo
Sector
Industrials
Industry
Commercial Services & Supplies
IPO DateMar 17, 1980

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(2.8K)

Expand
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers6 Oct
  • 4Statement of changes in beneficial ownership28 Sep
  • 4Statement of changes in beneficial ownership24 Sep
  • 3Initial statement of beneficial ownership8 Sep
  • 4Statement of changes in beneficial ownership2 Sep
  • 4Statement of changes in beneficial ownership26 Aug
  • 4Statement of changes in beneficial ownership20 Aug
  • 4Statement of changes in beneficial ownership18 Aug
  • 144King Debra18 Aug
  • 144STRYKER RONDA E17 Aug
  • 4Statement of changes in beneficial ownership4 Aug
  • 4Statement of changes in beneficial ownership4 Aug
  • 4Statement of changes in beneficial ownership4 Aug
  • 4Statement of changes in beneficial ownership4 Aug
  • 10-QQ2ended 30 Jun 202631 Jul
  • 8-KResults of Operations and Financial Condition30 Jul
  • 8-KOther Events26 Jun
  • 4Statement of changes in beneficial ownership2 Jun
  • 4Statement of changes in beneficial ownership29 May
  • 4Statement of changes in beneficial ownership28 May

News

  • Stryker Corporation $SYK Shares Purchased by CMH Wealth Management LLC23 Oct
  • Is It Too Late to Buy Stryker Corp (SYK) After 3.2% Rally? GF Value Says Undervalued22 Oct
  • These 2 dividend stocks are worth owning for a lifetime22 Oct
  • Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release22 Oct
  • 1,999 Stryker Corporation $SYK Shares Bought by Diversify Advisory Services LLC22 Oct
  • PAHC or SYK: Which Is the Better Value Stock Right Now?21 Oct
  • Stryker's Sonopet 3 Secures FDA Clearance to Improve Surgical Accuracy21 Oct
  • 2 Dividend Stocks to Buy and Hold Forever21 Oct
  • Mar Vista U.S. Quality Strategy Q3 2026 Portfolio Review21 Oct
  • 2 Industries Beyond AI With Long-Term Demand Drivers for 202719 Oct
  • Stryker Enters Soft-Tissue Robotics With $400 Million CMR Deal19 Oct
  • Securities Fraud Investigation Into Stryker Corporation (SYK) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm15 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK15 Oct
  • Stryker Corporation (SYK) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation15 Oct
  • Securities Fraud Investigation Into Stryker Corporation (SYK) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz14 Oct
  • Stryker launches Sonopet® 3, delivering greater power and precision in ultrasonic tissue removal14 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK13 Oct
  • Stryker: Q2 Recovery And Portfolio Expansion Strengthen The Operating Story13 Oct
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK8 Oct
  • The Monopolistic Razor-and-Blade Engine I Can’t Stop Buying8 Oct

Mentions in Filings

  • … ns, no natural person is deemed to hold any beneficiary ownership in these shares. The address of DCG is 290 Harbor Drive, 4th Floor, Stamford, CT 06902. (5) Front Range Ventures, LLC’s (“FRV”) sole member is the L. Lee <strong>Stryker</strong> Irrevocable Trust U/A/D 09/10/1974. Bohemian Asset Management, Inc. who has voting and dispositive power with respect to the shares of HeartSciences Common Stock on behalf of the L. Lee Stryker Irrevocable Trust U/A/D 09/ …
    HeartSciences Inc.Stryker Corp·DEFM14A - PROXY STATEMENT·Q2 27·19 Oct
  • … 5). While at Vivo, Dr. Yu also led investments in Zai Labs (NASDAQ: ZLAB), RiverVision (acquired by Horizon), CRISPR Therapeutics (NASDAQ:CRSP), Intellia (NASDAQ: NTLA), Durata (acquired by Actavis), Trauson (acquired by <strong>Stryker</strong>), and Revolution Medicines (NASDAQ:RVMD). Dr. Yu also serves on the California Board of Trustees for the Nature Conservancy (since August 2025) and ElevAATe Biotechnology (since November 2024), and was previously a member …
    TCGX Acquisition Corp. IIStryker Corp·424B4 - Prospectus filing (Rule 424(b)(4))·Q4 26·16 Oct
  • Major employers in Marathon Bank’s market area are United Medical Resources, <strong>Stryker</strong>, Aspirus, Advocate Aurora Health, Ascension-Wisconsin, ABB Campus, Linetec, Froedtert ThedaCare, Quad/Graphics, Inc., Kohl’s, Northwestern Mutual and Rockwell Automation. Competition We face competition within our market area both in making loans and attracting deposits. Our market area has a concentration of financial institutions that include large money c …
    Marathon Bancorp, Inc. /MD/Stryker Corp·ARS - Annual report to security holders·FY26·13 Oct
  • … y (“VB”). From January 2006 to August 2014, Mr. Gandhi served as Vice President of Corporate Finance and Strategic Planning at Small Bone Innovations, Inc., an extremities focused medical device company acquired by <strong>Stryker Corporation</strong>, and Centinel. While at VB, from October 2014 to September 2019, Mr. Gandhi was a member of Centinel’s senior leadership, and from January 2006 to September 2014, Mr. Gandhi spent the majority of his time at VB prov …
    Centinel Spine Holdco, Inc.Stryker Corp·S-1 - Registration statement (general form)·Q4 26·7 Oct
  • … rantors with the Commission pursuant to Rule 424(b) under the Securities Act. Unless otherwise indicated, capitalized terms used but not defined herein shall have the meanings set forth in the Senior Indenture. **Fraser <strong>Stryker</strong> PC LLO** 1501 Mike Fahey Street, Suite 400, Omaha, NE 68102— TEL: 402.341.6000 — FAX: 402.341.8290 Sysco Corporation 1390 Enclave Parkway Houston, Texas 77077 Page 2 October 6, 2026 The USD Senior Notes and the re …
    Sysco Holdings CorpStryker Corp·EX-5.4 - 8-K - Entry into a Material Definitive Agreement·Q2 27·6 Oct
  • … d issuance of the USD Junior Notes and the Guarantees. We hereby consent to the filing of this opinion letter as an exhibit to the above-described Form 8-K. Paul, Weiss, Rifkind, Wharton & Garrison LLP may rely on this opinion as to matters of Applicable Law in connection with any legal opinion by the same being rendered as an exhibit to the above-described Form 8-K on the date hereof. Sincerely, /s/ Fraser <strong>Stryker</strong> PC LLO FRASER STRYKER PC LLO
    Sysco Holdings CorpStryker Corp·EX-5.5 - 8-K - Entry into a Material Definitive Agreement·Q2 27·6 Oct

Key Stats

Trading

Px/Chg 1D$275.43 / +0.90%
Avg Volume2.41M
Beta0.17
Mkt Cap105.59B
FD Mkt Cap124.98B

Float

Shrs Out/Float383.36M / 347.76M
Short Float0.02%
Days to Cover2.36
Stock Repurchased$0.00

Current Valuation

EV117.95B
EV/EBITDA19.14
EV/Sales4.67
P/B4.60
P/S4.18
FCF Yield0.39%
ROE3.24%
ROA1.61%
Current Ratio2.11

Dividend

Cash$0.88
Yield114.06%
Yield (TTM)114.06%

Estimates

P/E31.64
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgMay '23Apr '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings81.2848.1040.3647.61128.61141.73
Price / Sales10.296.156.236.3115.2317.54
Price / Book Value6.016.836.876.914.874.60
Price / Free Cash Flow89.9955.7140.7340.8658.24254.43
ENTERPRISE VALUE METRICS
Enterprise Value131,160.7125,100.4138,258.4152,958.2121,541.3117,945.1
Enterprise Value / Sales11.376.786.746.7716.9519.59
Enterprise Value / EBITDA48.0431.1327.3430.9859.8790.87
Enterprise Value / EBIT60.8341.4234.3239.3470.91118.18

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue10.1%17,108.018,449.020,498.022,595.025,116.0
Gross Income10.7%10,709.011,040.012,494.013,980.016,065.0
EBITDA15%3,608.04,018.05,057.04,938.06,314.0
EBIT18.3%2,618.03,020.04,029.03,888.05,121.0
Net Income13%1,994.02,358.03,165.02,993.03,246.0
EPS (Diluted)12.6%5.226.178.257.768.40
BALANCE SHEET
Cash & ST Inv8%3,019.01,928.03,053.04,493.04,100.0
Total Assets8.4%34,631.036,884.039,912.042,971.047,844.0
Total Liabilities6.5%19,754.020,268.021,319.022,337.025,424.0
Total Shareholder Equity10.8%14,877.016,616.018,593.020,634.022,420.0
CASH FLOW
Net Operating Cash Flow11.5%3,263.02,624.03,711.04,242.05,044.0
Cap Ex9.7%-525.0-588.0-575.0-755.0-761.0
Free Cash Flow11.8%2,738.02,036.03,136.03,487.04,283.0

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)307.69
Basic Shares383.36
Market Cap117,956.3
Diluted Shares386.50
Fully Diluted Shares Outstanding386.50
Fully Diluted Market Cap118,922.2
+Consolidated Debt15,234.0
−In-the-Money Convertible Debt—
+Capital Leases350.0
+Operating Leases—
−Cash & Equivalents-2,878.0
−Short-term Investments-87.0
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value130,312.3

Segment data

Revenue

by Products and services

  • Medsurg62%
  • Orthopaedics38%

Revenue

by Geography

  • Emea52%
  • Asia Pacific35%
  • Other Foreign Countries13%

Related companies

Apple Inc.

AAPL US

Kla Corp

KLAC US

Medtronic Public Limited Company

MDT US

3M Company

MMM US

Northrop Grumman Corp /DE/

NOC US

Coherent Corp.

COHR US

Boston Scientific Corp

BSX US

Lenovo Group Ltd

LNVGY US

Garmin Ltd

GRMN US

HOYA Corporation

HOCPY US

Becton Dickinson & Co

0R19 LN

L3harris Technologies, Inc. /DE/

LHX US